drugset / Trial / NCT02535611

Evaluation of Memantine Versus Placebo on Ischemic Stroke Outcome

NCT02535611

Phase 3 Completed 47 enrolled Mazandaran University of Medical Sciences
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The researchers aim to investigate the effect of memantine on stroke outcome in a randomized double-blind placebo-controlled clinical trial.

Timeline

Start
2015-10
Primary completion
2016-10
Completion
2017-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Memantine Unknown 10 mg

Indications